M&A Deal Summary

Roche Acquires Constitution Medical Investors

On July 2, 2013, Roche acquired healthcare services company Constitution Medical Investors from Warburg Pincus for 220M USD

Acquisition Highlights
  • This is Roche’s 2nd transaction in the Healthcare Services sector.
  • This is Roche’s 21st largest (disclosed) transaction.
  • This is Roche’s 8th transaction in the United States.
  • This is Roche’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2013-07-02
Target Constitution Medical Investors
Sector Healthcare Services
Buyer(s) Roche
Sellers(s) Warburg Pincus
Deal Type Add-on Acquisition
Deal Value 220M USD

Target

Constitution Medical Investors

Boston, Massachusetts, United States
website
Constitution Medical Investors, Inc. (CMI) is the developer of a highly innovative hematology testing system, which is designed to provide faster and more accurate diagnosis of blood-related diseases, thereby improving patient care.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Roche

Basel, Switzerland

website

Category Company
Founded 1896
Sector Life Science
Employees100,920
Revenue 63.3B CHF (2022)
DESCRIPTION
Roche's corporate headquarters in Basel, Switzerland.
Roche's corporate headquarters in Basel, Switzerland.

Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.

DEAL STATS #
Overall 17 of 42
Sector (Healthcare Services) 2 of 2
Type (Add-on Acquisition) 15 of 35
State (Massachusetts) 1 of 5
Country (United States) 8 of 28
Year (2013) 1 of 1
Size (of disclosed) 21 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-02 Verum Diagnostica

Munich, Germany

Verum Diagnostica GmbH is developing, producing and marketing the Multiplate analyzer, test cells and reagents for the determination of platelet function in whole blood for use in hospital laboratories and near-patient settings, such as interventional cardiology, surgery and intensive care. Operating globally in more than 45 countries, the company is based in the biotech cluster and academic center of Munich, Germany.

Buy €11M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-02 Genia Technologies

Mountain View, California, United States

Genia is developing a potentially disruptive next generation sequencing technology with integrated circuits enabling massively parallel, single-molecule DNA sequencing.

Buy $125M

Seller(S) 1

SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 87 of 249
Sector (Healthcare Services) 5 of 14
Type (Add-on Acquisition) 33 of 90
State (Massachusetts) 3 of 7
Country (United States) 55 of 136
Year (2013) 9 of 21
Size (of disclosed) 52 of 63
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-17 Delonex Energy

London, United Kingdom

Delonex Energy is a Sub-Saharan oil and gas company focused on exploration, development and production. Delonex is currently active in Ethiopia, Kenya and Mozambique and the Transaction in Chad is part of the company’s strategy for expanding its portfolio in Central & West Africa. Delonex Energy is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-31 ReSearch Pharmaceutical Services

Fort Washington, Pennsylvania, United States

ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base.

Sell -
Mergr

Product

Company

Legal